Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
03/2012
03/28/2012CN102395545A Novel fused polycyclic compound and organic light emitting device
03/28/2012CN102391222A Novel hydroxamates as therapeutic agents
03/28/2012CN102391179A Method for preparing pyrithione salt dispersed solution by injection coprecipitation method
03/28/2012CN102391178A Method for controlling impurities of isoniazid
03/28/2012CN102391177A Novel tri-ether compound, as well as synthetic method, process and usages thereof
03/28/2012CN102391176A Method for preparing 2-chloro-6-trichloromethylpyridine
03/28/2012CN102391175A Green synthesis method for 2,2'-bipyridine-4,4'-dicarboxaldehydes
03/28/2012CN102391164A Diaryl thioether compound, preparation method and application of thereof in tumor resistance
03/28/2012CN102391147A Preparation and activity of aryl formyl amino cyclopropanecarboxylic acid
03/28/2012CN102391059A Method for synthesizing cyclopropyl alkyl aromatic compound
03/28/2012CN101218237B Oxime derivative and preparations thereof
03/28/2012CN101117332B Preparation method of 2-chloronicotinic acid
03/27/2012US8143412 Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)
03/27/2012US8143406 Process for the manufacture of HI-6 dimethanesulfonate
03/27/2012US8143242 Malonamide derivatives with antithrombotic activity
03/27/2012US8143057 Chelating agents and highly luminescent and stable chelates and their use
03/22/2012WO2012035421A2 Pyridine compounds and the uses thereof
03/22/2012WO2012034472A1 Cyano benzenedicarboxamide compounds, preparing methods and as agricultural insecticides uses thereof
03/22/2012WO2012034363A1 Compounds of hedgehog pathway inhibitors, pharmaceutical compositions containing the same and uses thereof
03/22/2012US20120071662 Preparing aminoarylalkyl compounds
03/22/2012US20120071661 Ionic Liquid Solvents
03/22/2012US20120071653 Human Adam-10 Inhibitors
03/22/2012US20120071520 Crystalline phases of 2'--biphenyl-2-carboxylic acid (2-pyridin-3-yl-ethyl)-amide
03/22/2012US20120071519 CRYSTALLINE FORMS OF A FACTOR Xa INHIBITOR
03/22/2012US20120071517 2-pyridinylethylcarboxamide derivatives and their use as fungicides
03/22/2012US20120071513 Compositions and Their Use as Anti-Tumor Agents
03/22/2012US20120071465 Mitochondrial activity inhibitors of cancer-initiating cells and use thereof
03/22/2012US20120071457 Metallo-beta-lactamase inhibitors
03/22/2012CA2811479A1 Pyridine compounds and the uses thereof
03/21/2012EP2431380A2 Macrocyclic antagonist of the motilin receptor for treatment of gastrointestinal dysmotility disorders
03/21/2012EP2431370A1 Monoacylated 1,2-diaminocycloalkanes
03/21/2012EP2431358A1 Method of preparing a factor XA inhibitor
03/21/2012EP2429996A2 Process for the preparation of histamine h3 receptor modulators
03/21/2012EP2429995A1 Aryl pyridine as aldosterone synthase inhibitors
03/21/2012EP2429994A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
03/21/2012EP2429993A1 Inhibitors of human immunodeficiency virus replication
03/21/2012EP2429979A1 Novel herbicides
03/21/2012EP2429593A2 Biomolecule complexes as contrast agents in positron emission tomography (pet) based methods for the assessment of organ function
03/21/2012EP2188254B1 Novel bradykinin b1-antagonists
03/21/2012EP2133335B9 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor
03/21/2012EP1954678B1 Novel nk1 and nk2 antagonists
03/21/2012EP1683788B1 Derivatives of pyridone and use thereof
03/21/2012CN1984895B Synthesis and uses of synephrine derivatives
03/21/2012CN1894215B Compounds for treatment of cell proliferative diseases
03/21/2012CN102382638A Application of pyridine compound for preparing acidization corrosion inhibitors
03/21/2012CN102382049A Method for synthesizing 2-ethoxycarbonylaminosulfonyl-N,N-dimethyl nicotinamide
03/21/2012CN102382048A Preparation method of methyl R-(+)-2-{4-[3-chloro-5-(trifluoromethyl)-2-pyridinyloxy]phenoxy}propanoate
03/21/2012CN102382047A Crystal of 1,2-dihydropyridine compound
03/21/2012CN102382046A Purification method of crude 2,3-dimethyl pyridine
03/21/2012CN102382045A Purification of 2,3-dimethyl pyridine
03/21/2012CN102382044A Purification method for 2,3-dimethylpyridine
03/21/2012CN102382043A Purification method for yellowed pyridine
03/21/2012CN102382042A Anthracene derivant and organic electroluminescence element using same
03/21/2012CN101687800B Glucokinase activator
03/21/2012CN101671296B New method for obtaining 2-chloro-3-methylpyridine from mixture of 2-chloro-5-methylpyridine and 2-chloro-3-methylpyridine
03/21/2012CN101573336B Chemical compounds of pyridine carboxamide used for 11-beta-HSDI inhibitor
03/21/2012CN101466694B Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
03/21/2012CN101337938B Method for synthesizing acetate ionic liquid
03/21/2012CN101298427B Diaryl urea compound and use thereof
03/21/2012CN101128429B Nk1 antagonists
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138350 N′-cyano-N-halogenalkylimidamide derivatives
03/20/2012US8138349 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate
03/20/2012US8138182 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
03/20/2012CA2683738C Indanone derivatives that inhibit prolyl hydroxylase
03/20/2012CA2676907C Tricyclic compounds and their use as glucocorticoid receptor modulators
03/20/2012CA2672656C Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
03/20/2012CA2553423C Heterocyclic compounds for use in the treatment of cancer and the inhibition of angiogenesis
03/20/2012CA2507765C Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
03/20/2012CA2504410C Bifunctional phenyliso(thio)cyanates; method and intermediate products for the production thereof
03/15/2012WO2012033061A1 Organic electroluminescent element and charge transport material
03/15/2012WO2012032261A1 Method for synthesising biaryl ether or biheteroaryl ether
03/15/2012WO2012032018A1 Heteroarylmethyl amides
03/15/2012WO2012032014A1 Ethyne derivatives, pharmaceutical compositions and uses thereof
03/15/2012WO2012031993A1 Novel n-hydroxy-benzamides for the treatment of cancer
03/15/2012WO2012031735A1 Compounds for organic photovoltaic devices
03/15/2012WO2012012307A9 Sulfonyl compounds which modulate the cb2 receptor
03/15/2012US20120065405 Process for producing pyridine carboxylic acids
03/15/2012US20120065247 Modulating ires-mediated translation
03/15/2012US20120065206 Compounds for treating proliferative disorders
03/15/2012US20120065204 Novel n-hydroxy-benzamids for the treatment of cancer
03/15/2012US20120065185 Substituted alkylamine derivatives and methods of use
03/15/2012US20120065066 Novel herbicides
03/15/2012US20120065064 Novel herbicides
03/15/2012US20120064032 Novel hydroxamates as therapeutic agents
03/15/2012CA2809736A1 N-hydroxy-benzamides for the treatment of cancer
03/15/2012CA2808665A1 Heteroarylmethyl amides
03/14/2012EP2428586A1 Dimeric and trimeric nucleic acid dyes, and associated systems and methods
03/14/2012EP2428509A1 Human adam-10 inhibitors
03/14/2012EP2428505A2 Process For Producing Pyridine Carbocyxlic Acids
03/14/2012EP2428231A2 Biomolecule complexes as contrast agents in Positron Emission Tomography (PET) based methods for the assessment of organ function
03/14/2012EP2427433A1 Solid forms of sulfonamides and amino acids
03/14/2012EP2427426A1 Insecticidal compounds
03/14/2012EP2427416A1 Substituted aromatic compounds and pharmaceutical uses thereof
03/14/2012EP1948608B1 Pharmaceutical salts and polymorphs of n-(5-chloro-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]benzoyl]amino]-5-methoxy-benzamide , a factor xa inhibitor
03/14/2012CN102378756A Solid forms of 2-(2, 4-difluorophenyl)-6-(1-(2,6-difluorophenyl)ureido)nicotinamide
03/14/2012CN102378753A Plasminogen activator inhibitor-1 inhibitor
03/14/2012CN102372713A Dual alanyl-aminopeptidase and dipeptidyl-peptidase iv inhibitors
03/14/2012CN102372670A Arylamine compounds containing arylpyridine groups and application of arylamine compounds containing arylpyridine group
03/14/2012CN102372669A Phenylene diamine compound and application thereof
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 633